M
MIG
Venture CapitalActiveMIG is a leading German VC investor, focussed on early to mid-stage technology and life science companies.
66
Investments
9
Exits
$1.5B
AUM
13.6%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for MIG.
Investment Thesis & Strategy
MIG invests in early to mid-stage technology and life science companies, leveraging their experience as a leading German VC investor.
Investment Activity
Deals per year over the last 16 years
1
20060
20072
20080
20090
20100
20110
20120
20131
20140
20150
20160
20172
20182
20190
20202
2021Portfolio Companies
Selected investments from their portfolio of 66 companies
M
MorphoSys
Biotech · Growth, 0
E
Evotec
Biotech · Growth, 0
C
Cantourage
Healthcare · Growth, 2021
S
SunMirror
Other · Growth, 2021
I
IonQ
Other · Growth, 2019
V
Vividion Therapeutics
Biotech · Growth, 2019
S
Sana Biotechnology
Biotech · Growth, 2018
I
InnoME
Biotech · Series A, 2018
R
Rigontec
Biotech · Series A, 2014
A
Apogenix
Biotech · Series A, 2008
B
BioNTech
Biotech · Series A, 2008
B
BRAIN Biotech
Biotech · Growth, 2006
Notable Exits
CompanyTypeYearValue / Acquirer
ApogenixAcquisition2021—
ImmaticsIPO2020—
SunMirrorIPO2020—
BioNTechIPO2019$150M
InflaRxIPO2017—
Ganymed PharmaceuticalsAcquisition2016$1.4B
MologenIPO2006—
EvotecIPO1999—
MorphoSysIPO1999—
Frequently Asked Questions
MIG focuses on Series A, Series B, Series C+ stage investments.